Ignite Creation Date:
2024-05-06 @ 7:46 PM
Last Modification Date:
2024-10-26 @ 3:13 PM
Study NCT ID:
NCT06126601
Status:
RECRUITING
Last Update Posted:
2024-06-13
First Post:
2023-08-07
Brief Title:
Incidence and Clinical Impact of Serum Hyperamylasemia POH After Pancreatectomy on Postoperative Outcome and Patient Safety
Sponsor:
Technische Universität Dresden
Organization:
Technische Universität Dresden
Study Overview
Official Title:
Incidence and Clinical Impact of Serum Hyperamylasemia POH After Pancreatectomy on Postoperative Outcome and Patient Safety
Status:
RECRUITING
Status Verified Date:
2024-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
HYPPO
Brief Summary:
Recent evidence suggests that postoperative hyperamylasemia POH is a predictor of morbidity after pancreatectomy This is based on the assumption that pancreatitis after pancreatectomy PPAP is a major trigger for the development of complications and is indicated by hyperamylasemia Standardized prospective analysis and correlation with other laboratory parameters hasnt been performed to date
Therefore the overall study aims are
To prospectively evaluate the incidence and assess the clinical value of biochemical changes for the postoperative course
To confirm and improve the definition and classification of postpancreatectomy acute pancreatitis PPAP of the International Study Group of Pancreatic Surgery ISGPS and to provide knowledge for effective early management of complications
Therefore the overall study aims are
To prospectively evaluate the incidence and assess the clinical value of biochemical changes for the postoperative course
To confirm and improve the definition and classification of postpancreatectomy acute pancreatitis PPAP of the International Study Group of Pancreatic Surgery ISGPS and to provide knowledge for effective early management of complications
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| DRKS00031860 | OTHER | German Clinical Trials Register | None |